
    
      Endometriosis is a chronic disease affecting 5-10% of women in reproductive age, showing
      recurrence after surgery at least in 20-50% after 5 years of follow-up. Aromatase inhibitor
      plus GnRH analog may be more effective than GnRH agonist alone in the treatment of
      endometriosis recurrence.
    
  